We are live on ! Find out more
CCG

Cypress Capital Group Portfolio holdings

AUM $889M
1-Year Est. Return 27.23%
This Fund
S&P 500
This Quarter Est. Return
-1.55%
1 Year Est. Return
+27.23%
3 Year Est. Return
+83.89%
5 Year Est. Return
+113.23%
10 Year Est. Return
+324.61%
AUM
$692M
AUM Growth
+$912K
Cap. Flow
+$18.6M
Cap. Flow %
2.68%
Top 10 Hldgs %
29.22%
Holding
311
New
13
Increased
109
Reduced
139
Closed
17

Sector Composition

Rank Sector Weight
1 Technology 19.33%
2 Healthcare 17.59%
3 Financials 10.31%
4 Consumer Discretionary 8.46%
5 Energy 7.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTRS icon
276
Viatris
VTRS
$20.4B
$231K 0.03%
23,393
SJM icon
277
J.M. Smucker
SJM
$12.7B
$228K 0.03%
+1,853
New +$263K
UCB
278
United Community Banks
UCB
$4.24B
$222K 0.03%
8,745
BSX icon
279
Boston Scientific
BSX
$69.5B
$219K 0.03%
+4,145
New +$217K
WMB icon
280
Williams Companies
WMB
$87.5B
$219K 0.03%
6,494
+335
+5% +$11.4K
CARR icon
281
Carrier Global
CARR
$51B
$217K 0.03%
+3,927
New +$216K
VFC icon
282
VF Corp
VFC
$5.63B
$215K 0.03%
12,160
-768
-6% -$14.6K
INVH icon
283
Invitation Homes
INVH
$17.7B
$215K 0.03%
6,778
-27
-0.4% -$928
MDLZ icon
284
Mondelez International
MDLZ
$79.5B
$212K 0.03%
3,061
+146
+5% +$10.5K
WST icon
285
West Pharmaceutical
WST
$24B
$211K 0.03%
563
AMH icon
286
American Homes 4 Rent
AMH
$12B
$210K 0.03%
6,229
-8
-0.1% -$287
ESS icon
287
Essex Property Trust
ESS
$18.3B
$209K 0.03%
987
-7
-0.7% -$1.64K
ZBH icon
288
Zimmer Biomet
ZBH
$18.2B
$206K 0.03%
1,838
LH icon
289
Labcorp
LH
$25.4B
$203K 0.03%
1,008
-165
-14% -$34.8K
IVW icon
290
iShares S&P 500 Growth ETF
IVW
$73.8B
$200K 0.03%
2,929
OMER icon
291
Omeros
OMER
$857M
$161K 0.02%
55,000
+5,000
+10% +$20.1K
ESBA icon
292
Empire State Realty Series ES
ESBA
$1.34B
$85.9K 0.01%
10,741
CDZI icon
293
Cadiz
CDZI
$251M
$49.6K 0.01%
15,000
VATE icon
294
INNOVATE Corp
VATE
$111M
$19.4K ﹤0.01%
1,200
-200
-14% -$3.34K
ADCT icon
295
ADC Therapeutics
ADCT
$134M
-10,000
Closed -$21.5K
ASML icon
296
ASML
ASML
$626B
-286
Closed -$207K
BIO icon
297
Bio-Rad Laboratories Class A
BIO
$8.71B
-984
Closed -$373K
BIV icon
298
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
-4,552
Closed -$342K
CRL icon
299
Charles River Laboratories
CRL
$11.2B
-956
Closed -$201K
INCY icon
300
Incyte
INCY
$24.2B
-3,262
Closed -$203K

Similar funds

Cypress Capital Group's Q3 2023 Portfolio in Review

As of Q3 2023, Cypress Capital Group held 311 positions worth $692M, up 0.13% from $691M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Cypress Capital Group's Q3 2023 filing shows 13 new, 109 increased, 139 reduced and 17 closed positions. Its largest new stake was Oneok: 15,785 shares worth $1M. The largest sale was RTX Corp, an estimated $2.48M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

  • Cypress Capital Group's largest Q3 2023 buy was Oneok: 15,785 shares worth $1M.
  • Cypress Capital Group added most to iShares Core S&P 500 ETF in Q3 2023, an estimated $11.1M increase.
  • Cypress Capital Group's biggest Q3 2023 reduction was RTX Corp, cutting an estimated $2.48M.
  • Cypress Capital Group fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $1.31M.
  • Cypress Capital Group's ten largest holdings make up 29% of its $692M portfolio in Q3 2023.
  • Cypress Capital Group opened 13 new positions and closed 17 in Q3 2023.
  • Cypress Capital Group's portfolio value rose 0.13% quarter-over-quarter to $692M.

Based on Cypress Capital Group's 13F filing for Q3 2023, filed 2 Nov 2023.